Patent Yard Sign in
Expired Canadian patentCanada

Murine hybridoma and diagnostic antibody produced thereby

CA 1295271 C · Owner: Rosen, Steven T. · Inventors: Rosen, Steven T.; Ma, Yixing; Radosevich, James A.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Hybridoma HB 8986 produces a murine monoclonal antibody which recognizes a new determinant expressed in bronchopulmonary carcinomas and A549 cell line derived tumors. Immunoperoxidase staining with the hybridoma on formalin fixed, paraffin embedded tissues shows that it specifically stains both the cytoplasmic and cell surface. The monoclonal antibody has the ability to distinguish preferably bronchopulmonary carcinomas with glandular differentiation from other bronchopulmonary carcinomas. Additionally the monoclonal antibody may identify, adenocarcinomas through the body.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted February 4, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 4, 2009.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 16, 1988
GrantedFebruary 4, 1992
Term endedFebruary 4, 2009
Patent numberCA 1295271 C
Classification (IPC)G01N33/57 +1 more

Timeline

Timeline From CIPO dates

1989199219951998200120042007Application filedNov 16, 1988Patent grantedFeb 4, 1992Term endedFeb 4, 2009

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.